MOLECULAR PARTNERS revenue breakdown overview

MOLECULAR PARTNERS revenue for the last year amounted to 7.00 M CHF, the most of which — 7.04 M CHF — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 189.60 M CHF. The greatest contribution to the revenue figure was made by Switzerland — last year it brought MOLECULAR PARTNERS 7.04 M CHF, and the year before that — 179.95 M CHF.